AbbVie Inc. (ABBV) vs Novartis AG (NVS)
AbbVie Inc. and Novartis AG are both Drug Manufacturers General companies. AbbVie Inc. is the larger, with a market value of $467.4B against $264.3B — 1.8× the size. Novartis AG trades at the lower P/E: 21.8× against 74.7×. AbbVie Inc. grew revenue faster over the last twelve months: 10.4% against 2.73%. Novartis AG has the higher net margin (22.5% vs 9.74%) and the lower return on invested capital (13.1% vs 18.1%). Both pay a dividend; Novartis AG yields more (3.69% vs 3.57%). Across the 22 metrics below, Novartis AG leads on 17 and AbbVie Inc. on 5.
Valuation
Profitability
| Metric | ABBV | NVS | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 71.48% | 74.74% | 72.77% |
| Operating margin | 26.20% | 30.17% | 18.90% |
| Net margin | 9.74% | 22.50% | 8.27% |
| Free cash flow margin | 28.28% | 26.77% | 17.25% |
| Return on equity | (208.10%) | 30.37% | 6.97% |
| Return on assets | 4.61% | 11.27% | 2.76% |
| Return on invested capital | 18.07% | 13.14% | 6.30% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack